Altered expression of apoptotic genes in response to OCT4B1 suppression in human tumor cell lines

Mohammad Reza Mirzaei1, Ali Najafi, Mohammad Kazemi Arababadi

  • 1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

Insights

The study reveals that suppressing OCT4B1, a gene overexpressed in tumors, alters apoptotic gene expression. This suppression upregulates pro-apoptotic genes and downregulates anti-apoptotic genes in cancer cells, suggesting OCT4B1 as a potential cancer therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • OCT4B1 is a spliced variant of OCT4, predominantly found in pluripotent and tumor cells.
  • OCT4B1 overexpression in tumors confers anti-apoptotic properties, but its regulatory mechanism remains unclear.
  • Understanding OCT4B1's role in apoptosis is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To investigate the impact of OCT4B1 suppression on the expression of genes within the apoptotic pathway.
  • To identify specific apoptotic genes regulated by OCT4B1 in various cancer cell lines.
  • To elucidate the mechanism by which OCT4B1 influences tumor cell survival.

Main Methods:

  • Utilized siRNA to suppress OCT4B1 expression in AGS, 5637, and U-87MG cancer cell lines.
  • Quantified the expression levels of 84 apoptosis-related genes using a human apoptosis panel-PCR kit.
  • Analyzed gene expression alterations across different tumor cell types to identify common patterns.

Main Results:

  • OCT4B1 suppression led to significant expression changes in over 54% of the investigated apoptotic genes across all tested cell lines.
  • Key pro-apoptotic genes (e.g., CASP7, TNFRSF1A) were upregulated, while anti-apoptotic genes (e.g., BCL2, BAX) were downregulated.
  • The observed gene expression pattern indicated a shift towards apoptosis induction upon OCT4B1 knockdown.

Conclusions:

  • OCT4B1 suppression effectively modulates the apoptotic pathway in tumor cells.
  • Targeting OCT4B1 could reverse the anti-apoptotic effect in cancer cells, promoting cell death.
  • Identifying OCT4B1 downstream targets offers a promising avenue for developing new anti-cancer strategies.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K